Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
Clinical trial NCT03469960 · COMPLETED
Trial details
- NCT number
- NCT03469960
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2023-11-08
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.